Lessons from a Pandemic to look forward in 2021 | UPSC
Lessons from a pandemic: What India can look forward to in 2021 from health and science
WHY IN NEWS:
The Covid-19 pandemic has brought rare attention to science, particularly aspects related to healthcare, and India’s response has underlined its existing scientific capabilities.
SYLLABUS COVERED: GS 3:Health:Diseases
LESSONS FROM A PANDEMIC TO LOOK FORWARD IN 2021
- Thanks to the Covid-19 epidemic, 2020 brought rare attention on science, particularly on the health sciences.
- Subjects like public health, the mechanism of spread of viral diseases, or the state of country’s scientific research become part of mainstream discussions.
- A large number of people even became aware of issues like the intricacies of vaccine development, or the difficulties in clinical trials of drugs and vaccines.
- Science, and the tools it has gifted, was the primary weapon to be deployed in the fight against the pandemic.
NOT AS BAD AS FEARED
- India hasn’t fared as badly as many had feared at the start of the outbreak.
- This is not to belittle the nearly 1.5 lakh deaths that have been attributed to the disease, or the millions whose livelihood has been affected.
- But, considering India’s population and density, the disregard for public hygiene, and the rickety public health infrastructure, much worse had been predicted.
- Part of it could be attributed to sheer luck, at least until we fully understand the biological reasons behind the steady decline in the number of cases in the last three months.
- The disease has been much less severe in India, and has caused much fewer deaths on an average.
- There was a lot that did not go right, but most of these related to administrative decisions, or the lack of effective communication.
INHERENT SCIENTIFIC CAPACITIES
- India could benefit from the fairly robust science and technology infrastructure and network it has built over the years.
- Nothing exemplified this better than the ramping up of number of diagnostic tests that were carried out to detect coronavirus infections.
- It started with just one laboratory in Pune, but very soon more than 1,500 laboratories, government as well as private, had begun testing samples.
- At its peak, India was testing 14 to 15 lakh samples every day.
- India could not manufacture them domestically, but probably it was more cost-effective to get it from abroad.
- The supply became increasingly uncertain due to travel restrictions, and burgeoning global demand.
- In a matter of weeks, Indian companies in collaboration with research institutions began producing these at home.
- New, more economical, diagnostic tests were developed and deployed. PPE kits was no longer in short supply.
- Similar was the case with equipment like ventilators and oxygen meters.
- The private industry, especially small start-ups, contributed in a big way to filling the demand gap.
- In some cases, more than 100 contacts of an infected person were traced, tested and isolated.
- It showed that while the primary healthcare network might be weak, and not empowered, it was not entirely broken.
- Vaccines are another area where India’s existing capacities are a big asset, and can be leveraged effectively.
- That would also mean that India would also get early access to these vaccines.
- The government not having to spend large sums of money like the United States or some European countries had to do to pre-book the vaccines.
- The first vaccine is likely to become available not later than a few weeks from now.
- Early logistical planning for transport, storage and distribution already having been finalised would ensure quick deployment.
- The Covid-19 pandemic invariably turns out to be a blessing in disguise for making systemic improvements, if those in command are willing to imbibe the lessons that have emerged.
- Here are some of the things that we are likely to see happening in the science and technology, and health, sectors in the coming months and years.
- If anything, the experience of this pandemic has made the government more convinced of the need for self-reliance, at least in the strategic sectors.
- And that would include the science and technology sector as well.
- Going forward, there is likely to be greater encouragement for laboratories and industry to support domestic manufacturing of components and instruments.
- Scientists and industry expect relevant policy changes in the coming year.
PROMOTING STAR-UP CULTURE
- This is related to the atmanirbhar push.The state had been promising support to start-up ventures long before the outbreak.
- But the pandemic also showed how important this is. It was these start-ups that filled the supply gaps in medical equipment and instruments.
- About half a dozen new space-related enterprises have sprung up in the last two years,.
- A similar push is expected for start-ups in the health sector as well.
- Collaboration between government, academia and industry is again a process that was initiated before the pandemic but is likely to gain momentum.
- In most of these missions, or hubs, it is the industry or the academia that is playing the lead role, while the government tries to facilitate an enabling environment.
STRONGER HEALTH SYSTEM
- The dreadful aspect of the pandemic is that it might not be the last one.In the last few years, we have seen outbreaks of several viral diseases.
- Thankfully, they never became as widespread as the current one.
- But that is no guarantee that a future one would not be more infectious, or deadly.
- Greater empowerment of primary healthcare staff is also expected.
- The ICMR, was put in the forefront of the fight against the epidemic, the Integrated Disease Surveillance Programme (IDSP), set up in 2004 for precisely this purpose, was pushed in the background.
- Though the existing vaccine manufacturing capacity is coming in handy, India has been found wanting in development of its own vaccine.
- As of now, there are only two Indian candidates in stage three clinical trials.
- But that has traditionally been one of the weak points, which some research institutions now want to address.
NEW SCIENCE POLICY
- A new Science, Technology, and Innovation Policy is in the final stages of preparation, and is likely to be unveiled in the next three to four months.
- It is expected to do to the science sector what the National Education Policy, released earlier this year, seeks to do for education.
- Not unexpectedly, it is likely to be heavily influenced by the lessons learnt during the pandemic.
SOURCES: IE | Lessons from a Pandemic to look forward in 2021 | UPSC